Abrocitinib

Abrocitinib (brand names Cibinqo, Jabryus) is an oral medication for adults with moderate-to-severe atopic dermatitis (eczema) that works by blocking JAK1 enzymes to reduce inflammation, itch, and skin redness, offering relief and improving quality of life. Approved by the FDA, EMA, and other agencies, it's a systemic treatment offering rapid itch relief but requires monitoring for side effects like infections, increased cholesterol, and potential serious issues like blood clots or cancer, with specific precautions for older adults and those with kidney/liver issues.